Downloadable Slidesets

Share

Program Content

Activities

  • <i>MET</i> Mutations in NSCLC
    MET Mutations: Mastering the Features of and Testing for a New Target in NSCLC
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 29, 2020

    Expires: May 28, 2021

  • MET TKIs in <i>MET</i>ex14+ NSCLC: Tepotinib
    MET-Targeted Therapies in Development: Tepotinib, Crizotinib, Savolitinib, and Combinations
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 29, 2020

    Expires: May 28, 2021

  • MET TKIs in <i>MET</i>ex14+ NSCLC: Capmatinib
    MET-Targeted Therapies in Development: Capmatinib, Acquired Resistance to MET TKIs, and Next-Line Choices
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 29, 2020

    Expires: May 28, 2021

Provided by

ProCE Banner

Supporters

Merck KGaA